OrthoBiologics Market to Register 5.5% CAGR by 2031, Amidst Rise in the Elderly and Obese Population
The global ageing population and growing awareness of the benefits of orthobiologic therapy are driving the size of the global orthobiologics market.
ncbiotech.org1d
Cellectis Announces First Patient to Receive CAR T-Cell Therapy Candidate Made in its Raleigh Facility
Paris-based biotechnology company Cellectis (NASDAQ: CLLS) has announced the first patient in the U.S. to receive a dose of its UCART22 allogeneic CAR T-cell therapy product candidate that was ...